Literature DB >> 9119477

Identification of the ADP-L-glycero-D-manno-heptose-6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae 2019.

W A Nichols1, B W Gibson, W Melaugh, N G Lee, M Sunshine, M A Apicella.   

Abstract

Haemophilus influenzae is an important human pathogen. The lipooligosaccharide (LOS) of H. influenzae has been implicated as a virulence determinant. To better understand the assembly of LOS in nontypeable H. influenzae (NtHi), we have cloned and characterized the rfaD and rfaF genes of NtHi 2019, which encode the ADP-L-glycero-D-manno-heptose-6-epimerase and heptosyltransferase II enzymes, respectively. This cloning was accomplished by the complementation of Salmonella typhimurium lipopolysaccharide (LPS) biosynthesis gene mutants. These deep rough mutants are novobiocin susceptible until complemented with the appropriate gene. In this manner, we are able to use novobiocin resistance to select for specific NtHi LOS inner core biosynthesis genes. Such a screening system yielded a plasmid with a 4.8-kb insert. This plasmid was able to complement both rfaD and rfaF mutants of S. typhimurium. The LPS of these complemented strains appeared identical to the wild-type Salmonella LPS. The genes encoding the rfaD and rfaF genes from NtHi 2019 were sequenced and found to be similar to the analogous genes from S. typhimurium and Escherichia coli. The rfaD gene encodes a polypeptide of 35 kDa and the rfaF encodes a protein of 39 kDa, as demonstrated by in vitro transcription-translation studies. Isogenic mutants which demonstrated truncated LOS consistent with inner core biosynthesis mutants were constructed in the NtHi strain 2019. Primer extension analysis demonstrated the presence of a strong promoter upstream of rfaD but suggested only a very weak promoter upstream of rfaF. Complementation studies, however, suggest that the rfaF gene does have an independent promoter. Mass spectrometric analysis shows that the LOS molecules expressed by H. influenzae rfaD and rfaF mutant strains have identical molecular masses. Additional studies verified that in the rfaD mutant strain, D-glycero-D-manno-heptose is added to the LOS molecule in place of the usual L-glycero-D-manno-heptose. Finally, the genetic organizations of the inner core biosynthesis genes of S. typhimurium, E. coli, and several strains of H. influenzae were examined, and substantial differences were uncovered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119477      PMCID: PMC175143          DOI: 10.1128/iai.65.4.1377-1386.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.

Authors:  A Zwahlen; L G Rubin; E R Moxon
Journal:  Microb Pathog       Date:  1986-10       Impact factor: 3.738

2.  Defined nongrowth media for stage II development of competence in Haemophilus influenzae.

Authors:  R M Herriott; E M Meyer; M Vogt
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype.

Authors:  I M Helander; B Lindner; H Brade; K Altmann; A A Lindberg; E T Rietschel; U Zähringer
Journal:  Eur J Biochem       Date:  1988-11-15

6.  Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence.

Authors:  A Kimura; C C Patrick; E E Miller; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence.

Authors:  A Kimura; E J Hansen
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Characterization of two transposon mutants from Haemophilus influenzae type b with altered lipooligosaccharide biosynthesis.

Authors:  N J Phillips; R McLaughlin; T J Miller; M A Apicella; B W Gibson
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

View more
  19 in total

1.  Inactivation of Haemophilus influenzae lipopolysaccharide biosynthesis genes interferes with outer membrane localization of the hap autotransporter.

Authors:  Nicole A Spahich; Derek W Hood; E Richard Moxon; Joseph W St Geme
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

2.  Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media.

Authors:  T F DeMaria; M A Apicella; W A Nichols; E R Leake
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose.

Authors:  M A Valvano; C L Marolda; M Bittner; M Glaskin-Clay; T L Simon; J D Klena
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

4.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

5.  A Novel Glaesserella sp. Isolated from Pigs with Severe Respiratory Infections Has a Mosaic Genome with Virulence Factors Putatively Acquired by Horizontal Transfer.

Authors:  Anne E Watt; Glenn F Browning; Alistair R Legione; Rhys N Bushell; Andrew Stent; Ross S Cutler; Neil D Young; Marc S Marenda
Journal:  Appl Environ Microbiol       Date:  2018-05-17       Impact factor: 4.792

6.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Partial analysis of the genomes of two nontypeable Haemophilus influenzae otitis media isolates.

Authors:  Robert S Munson; Alistair Harrison; Allison Gillaspy; William C Ray; Matt Carson; David Armbruster; Jenny Gipson; Mandy Gipson; Linda Johnson; Lisa Lewis; David W Dyer; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Differential expression of cytokine genes and iNOS induced by nonviable nontypeable Haemophilus influenzae or its LOS mutants during acute otitis media in the rat.

Authors:  Hua Hua Tong; Yiping Chen; Xia Liu; Thomas F DeMaria
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-06-03       Impact factor: 1.675

9.  Effect of lipooligosaccharide mutations of Haemophilus influenzae on the middle and inner ears.

Authors:  Patricia A Schachern; Vladimir Tsuprun; Beinan Wang; Michael A Apicella; Sebahattin Cureoglu; Michael M Paparella; Steven K Juhn
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-10-22       Impact factor: 1.675

10.  Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: an htrB mutation diminishes the colonization of human airway epithelial cells.

Authors:  W Edward Swords; Deborah L Chance; Leah A Cohn; Jianqiang Shao; Michael A Apicella; Arnold L Smith
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.